Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NAFLD, Diabetes, Type 2, Hypertriglyceridemia Trial in Canada, United States (Placebo, ISIS 703802 40 mg, ISIS 703802 80 mg)

Completed
Has Results
  • NAFLD
  • +3 more
  • Placebo
  • +3 more
  • Chandler, Arizona
  • +41 more
Jan 28, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +102 more
Jan 14, 2021

Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Searcy, Arkansas
  • +157 more
Nov 13, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Diabetes, Type 2 Trial in United States (Dulaglutide Pen, Semaglutide Pen)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Dulaglutide Pen
  • Semaglutide Pen
  • Fresno, California
  • +13 more
Apr 10, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +118 more
Feb 14, 2020

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathy
  • Birmingham, Alabama
  • +592 more
Dec 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +208 more
Oct 2, 2019

Diabetes, Type 2 Trial in Worldwide (LY2409021, Sitagliptin, Placebo)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +32 more
Sep 25, 2019

Obesity, Morbid Obesity, Diabetes, Type 2 Trial in Chicago (Intermittent Fasting)

Unknown status
  • Obesity
  • +3 more
  • Intermittent Fasting
  • Chicago, Illinois
    The University of Chicago
Sep 18, 2019

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Type 2 Trial in United States (Lyophilized albiglutide DCC pen injector, Lyophilized albiglutide DCC pen injector

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lyophilized albiglutide DCC pen injector
  • +3 more
  • Birmingham, Alabama
  • +69 more
Jul 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +145 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Type 2 Trial in Worldwide (ipragliflozin, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +58 more
May 20, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

Terminated
  • Diabetes Mellitus, Type 2
  • ITCA 650 20/60 mcg/day
  • +2 more
  • Fountain Hills, Arizona
  • +100 more
Mar 4, 2019

Diabetes, Type 2 Trial in Chicago, Morehead City, El Paso (Albiglutide, Placebo)

Withdrawn
  • Diabetes Mellitus, Type 2
  • Chicago, Illinois
  • +2 more
Jan 16, 2019